altimmune glp-1 ALTIMMUNE, INC._December 31, 2024 Readout Newsletter: Altimmune, Eli Lilly,

Selina Wang reports on Medicares $50 GLP-1 weight-loss drug program, while Heidi Skolnik breaks down long-term benefits, risks and how patients should approach use of the medications.

Overall, the EASD-ADA consensus provides a dynamic framework that supports a multifaceted, patient-centric approach to type 2 diabetes care, aiming to reduce complications, improve quality of life, and promote long-term health outcomes

GLP-1 medications like Zepbound can trigger or worsen acid reflux in some patients

Safe & sustainable weight loss based on science

Nausea Relief Patch

Records were reviewed for patient characteristics and medication type and doses